Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ)

CAPS Rating: 2 out of 5

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.

Recs

0
Player Avatar reddingrunner (81.93) Submitted: 2/1/2012 1:06:04 PM : Outperform Start Price: $48.38 JAZZ Score: -4.55

sabrient systems

Featured Broker Partners


Advertisement